Theses and Dissertations from UMD

Permanent URI for this communityhttp://hdl.handle.net/1903/2

New submissions to the thesis/dissertation collections are added automatically as they are received from the Graduate School. Currently, the Graduate School deposits all theses and dissertations from a given semester after the official graduation date. This means that there may be up to a 4 month delay in the appearance of a give thesis/dissertation in DRUM

More information is available at Theses and Dissertations at University of Maryland Libraries.

Browse

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    IDENTIFICATION OF A NOVEL ANTI-APOPTOTIC GENE OF MYCOBACTERIUM TUBERCULOSIS
    (2012) Hurley, Benjamin; Briken, Volker; Cell Biology & Molecular Genetics; Digital Repository at the University of Maryland; University of Maryland (College Park, Md.)
    Over the next 20 years, more than 36 million people are expected to die of Mycobacterium tuberculosis (Mtb) related illness. We may prevent this only by learning as much as possible about the Mtb-mediated exploitation of the human immune system and successfully implementing that knowledge to combat the pathogen. One Mtb virulence mechanism involves inhibition of host apoptosis. An Mtb laden macrophage will attempt cell suicide, subsequently destroying any intracellular bacteria. In prior work, a large gain-of-function screen identified Mtb genomic regions involved in host apoptotic suppression; one such region is "K20." A loss-of-"gain-of-function" (LoGoF) screen involving in vitro transposon (Tn) mutagenesis of a K20 expressing vector identified individual gene(s) of K20 potentially responsible the virulence phenotype. This LoGoF screen found two unique K20 Tn-clones that consistently induced significant host apoptosis. These Tn's disrupted expression of K20 genes Rv2666 ( probable truncated transposase) and Rv2667 ( possible Clp ATPase). A Himar1 Tn mutant of Rv2666 was obtained through the TARGET mutant library project. Upon infection of human macrophages, TnRv2666 induced significantly more host apoptosis than wild type (WT) and complement, confirming Rv2666 as an anti-apoptotic gene of Mtb. There are no current publications suggesting a specific role for transposase-based virulence in Mtb; Rv2666 may affect an anti-apoptotic phenotype by modulating transcription of factors important for the suppression of host apoptosis. The second LoGoF identified gene, Rv2667/clpC2/clpX', was not available through TARGET; a recombinant ΔclpC2 mutant was generated. Comparing induced host apoptosis of ΔclpC2 infected macrophages to WT revealed Rv2667/clpC2 has no essential role as an anti-apoptotic gene of Mtb. ΔclpC2 was further characterized to explain the discrepancy between the initial LoGoF data and the ΔclpC2 Mtb results. Study of ΔclpC2 determined that it bears no significant differences with WT in terms of in vitro growth, host necrosis-induction, in vivo survival and induced host TNFα secretion levels. However, ΔclpC2 induces significantly more host IL-1β release than WT Mtb. The reason for this effect is unknown; ClpC2 may aid Mtb pathogenicity by limiting host inflammation, thus permitting infecting Mtb a "head start" against a host adaptive immune response.